What is Clinical Urine Testing Market?
Clinical urine testing is an examination of urine for certain physical properties, solutes, cells, casts, crystals, organisms, or particulate matter, and primarily used for medical diagnosis. It is used to detect and manage a wide range of disorders such as kidney disorders, UTI (urinary tract infection) and diabetes. It helps in the early detection of serious diseases.
The market study is being classified by Type (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables and PoC Analyzers), by Application (UTI, Diabetes, Pregnancy and Others) and major geographies with country level break-up.
Siemens Healthineers AG (Germany), Roche Holding AG (Switzerland), Beckman Coulter (United States), Sysmex Corporation (Japan), 77 Elektronika Kft. (Hungary), Analyticon Biotechnologies AG (Germany), ERBA Diagnostics (United States), ACON Laboratories, Inc. (United States), A. Menarini Diagnostics Ltd. (Italy) and URIT Medical Electronic Ltd. (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bio-Rad Laboratories (United States) and ACON Laboratories (United States).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Clinical Urine Testing market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Clinical Urine Testing market by Type, Application and Region.
On the basis of geography, the market of Clinical Urine Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Growing Global Prevalence of Kidney Diseases and Urinary Tract Infections
- Shift Towards Automation in Sediment Analysis
- Growth in the Healthcare Infrastructure in Developing Regions
Market Trend
- Increasing Adoption of Point-Of-Care Urinalysis
Restraints
- High Cost of the Instruments
Opportunities
- Growth in the Healthcare Industry
- Increasing Number of Diagnostic Centres
Challenges
- Lack of Skilled Professionals
Market Leaders and some development strategies
Abbott Laboratories announced its acquisition worth USD 5300 million with Alere Inc. to increase its business presence in the global market of urinalysis analyzers.
Bio-Rad Laboratories launched a new product called Quantify Advance Control for urinalysis testing. It is used for accurate analysis of the medical procedures in the urinalysis analyzers.
Key Target Audience
Clinical Urine Testing Instruments Providers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users